本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

和黄医药

13.89
+0.13000.94%
盘后13.890.00000.00%16:05 EDT
成交量:2.80万
成交额:38.50万
市值:23.75亿
市盈率:69.45
高:13.93
开:13.60
低:13.53
收:13.76
数据加载中...
2020/07/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/29

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/03

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

SEC问询函

CORRESP [Cover] - Correspondence